Total Payments
$6,117
2024 Payments
$957.03
Companies
41
Transactions
275
Medicare Patients
2,099
Medicare Billing
$126,027
Payment Breakdown by Category
Food & Beverage$5,638 (92.2%)
Education$478.63 (7.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,638 | 266 | 92.2% |
| Education | $478.63 | 9 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $655.67 | 31 | $0 (2024) |
| Teleflex LLC | $619.61 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $485.81 | 27 | $0 (2024) |
| PFIZER INC. | $448.61 | 35 | $0 (2024) |
| NeoTract Inc. | $302.20 | 11 | $0 (2020) |
| Amgen Inc. | $300.59 | 13 | $0 (2019) |
| AbbVie, Inc. | $274.47 | 17 | $0 (2019) |
| Antares Pharma, Inc. | $252.05 | 12 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $235.96 | 11 | $0 (2019) |
| Medtronic, Inc. | $232.65 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.03 | 38 | Teleflex LLC ($264.40) |
| 2023 | $253.21 | 9 | Medtronic, Inc. ($103.70) |
| 2022 | $716.57 | 9 | Teleflex LLC ($208.73) |
| 2021 | $264.37 | 5 | Teleflex LLC ($146.48) |
| 2020 | $225.19 | 12 | Coloplast Corp ($52.71) |
| 2019 | $1,060 | 62 | PFIZER INC. ($176.75) |
| 2018 | $1,712 | 93 | Astellas Pharma US Inc ($193.17) |
| 2017 | $928.07 | 47 | Astellas Pharma US Inc ($150.95) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $41.40 | General |
| 12/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $28.87 | General |
| 11/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $53.26 | General |
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: HORMONE THERAPY | ||||||
| 10/01/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: HORMONE THERAPY | ||||||
| 09/04/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: UROLOGY | ||||||
| 07/11/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Urology Gynecology | ||||||
| 07/10/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: UROLOGY | ||||||
| 07/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: HORMONE THERAPY | ||||||
| 06/26/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/17/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 658 | 771 | $129,877 | $34,431 |
| 2022 | 4 | 433 | 554 | $140,705 | $32,739 |
| 2021 | 6 | 394 | 526 | $105,194 | $28,186 |
| 2020 | 9 | 614 | 740 | $104,178 | $30,671 |
Total Patients
2,099
Total Services
2,591
Medicare Billing
$126,027
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 181 | $47,594 | $13,928 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 253 | $47,898 | $11,993 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $15,726 | $3,793 | 24.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 20 | 22 | $7,779 | $1,795 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,261 | $1,225 | 37.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 76 | 82 | $4,100 | $661.94 | 16.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 25 | 27 | $1,377 | $486.54 | 35.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 104 | 111 | $1,332 | $244.20 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 23 | $460.00 | $193.20 | 42.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 14 | 14 | $350.00 | $110.74 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 215 | 278 | $55,617 | $12,837 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 177 | $52,180 | $12,529 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $20,379 | $4,523 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 40 | 49 | $12,529 | $2,849 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 208 | 304 | $46,384 | $13,595 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 115 | $27,035 | $8,495 | 31.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $13,080 | $2,904 | 22.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 26 | 33 | $10,667 | $1,958 | 18.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,140 | $886.37 | 21.4% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 13 | 18 | $3,888 | $347.98 | 9.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 241 | 305 | $46,013 | $11,117 | 24.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 12 | 51 | $15,657 | $8,736 | 55.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 51 | $11,768 | $3,072 | 26.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $11,400 | $2,750 | 24.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 21 | 26 | $8,042 | $2,014 | 25.0% |
About Dr. Zachary Passaretti, MD
Dr. Zachary Passaretti, MD is a Urology healthcare provider based in Latham, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750357349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zachary Passaretti, MD has received a total of $6,117 in payments from pharmaceutical and medical device companies, with $957.03 received in 2024. These payments were reported across 275 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,638).
As a Medicare-enrolled provider, Passaretti has provided services to 2,099 Medicare beneficiaries, totaling 2,591 services with total Medicare billing of $126,027. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Latham, NY
- Active Since 02/24/2006
- Last Updated 10/15/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1750357349
Products in Payments
- XTANDI (Drug) $689.40
- UROLIFT (Device) $337.47
- ZYTIGA (Drug) $336.50
- UroLift (Device) $290.86
- INTERSTIM (Device) $260.45
- Prolia (Biological) $247.10
- GEMTESA (Drug) $241.85
- ELIGARD (Drug) $236.46
- XIAFLEX (Biological) $235.96
- Erleada (Drug) $199.18
- XYOSTED (Drug) $192.48
- Myrbetriq (Drug) $167.98
- UroLift System (Device) $158.61
- Desara (Device) $150.19
- ERLEADA (Drug) $149.08
- Androgel (Drug) $137.25
- Xtandi (Drug) $116.70
- BOTOX THERAPEUTIC (Biological) $110.78
- General - Vascular Access (Device) $104.70
- SPEEDICATH (Device) $103.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Latham
James Belarmino, Md, MD
Urology — Payments: $13,989
Urology $13,989
Dr. Matthew Stringer, D.o, D.O
Urology — Payments: $6,223
Urology $6,223
Dr. Carla Beckham, Md/Phd, MD/PHD
Urology — Payments: $3,098
Urology $3,098
Dr. Efrossini Kolios, Md, MD
Urology — Payments: $2,610
Urology $2,610
Yoram Beer, Md, MD
Urology — Payments: $2,125
Urology $2,125
Dr. Donald Bentrovato, Md, MD
Urology
Urology